The Action Mechanism of the Purified Platelet Aggregation Principle of Trimeresurus mucrosquamatus Venom

Summary

The minimal concentration of the platelet aggregation principle (Platelet Aggregoserpen- tin, PAS) necessary to induce platelet aggregation was 10 ng/ml, about one-hundredth of that of the crude venom. PAS induced the release of platelet factors 3 and 4 from platelets, but the released platelet factor 3 was easily inactivated by the anti-phospholipid effect of PAS. Pretreatment of platelets with neuraminidase potentiated PAS-induced platelet aggregation. PAS-induced platelet aggregation was independent on released ADP; it could occur in the ADP-removing systems, such as apyrase or a combination of phosphoenolpyruvate and pyruvate kinase. However, PAS-induced platelet aggregation could be inhibited by adenine nucleotides and adenosine.

PAS-induced platelet aggregation was inhibited by some anti-inflammatory agents, antimalarial drugs, local anesthetics, antihistamine and smooth muscle relaxants. After deaggregation of PAS-treated platelets, thrombin and sodium arachidonate could further induce platelet aggregation, but ADP and second dose of PAS could not. It is concluded that PAS-induced platelet aggregation is due to prostaglandin synthesis. Recent literatures on the mechanism of platelet aggregation were surveyed and the actions of PAS were discussed.

• References

• 1 Aledort LM, Niemetz J. 1968; Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proceedings of the Society for Experimental Biology and Medicine 128: 658
• 2 Ardlie NG, Glew G, Schultz BG, Schwartz CJ. 1967; Inhibition and reversal of platelet aggregation by methylxanthines. Thrombosis et Diathesis Haemorrhagica 18: 670
• 3 Ardlie NG, Perry DW, Packham MA, Mustard JF. 1971; Influence of apyrase on stability of suspensions of washed rabbit platelets. Proceedings of the Society for Experimental Biology and Medicine 136: 1021
• 4 Biran H, Dvilansky A, Nathan I, Live A. 1974; Impairement of human platelet aggregation and serotonin release caused in vitro by Echis colorata venom. Thrombosis et Diathesis Haemorrhagica 30: 191
• 5 Boffa MC, Boffa GA. 1974 Correlations between the enzymatic and factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochimica et Biophysica Acta.
• 6 Boffa MC, Delori P, Soulier JP. 1972; Anticoagulant factors from Viperidae venoms. Platelet phospholipid inhibitors. Thrombosis et Diathesis Haemorrhagica 28: 509
• 7 Bond GH, Hudgins PM. 1976; Inhibition of ATPase activity in human red cell membranes by tetracaine. Biochemical Pharmacology 25: 267
• 8 Born GV R, Cross MJ. 1963; The aggregation of blood platelet. Journal of Physiology 168: 178
• 9 Bradlow BA, Marcus AJ. 1966; Action of snake venom phospholipase A on isolated platelet membranes. Proceedings of the Society for Experimental Biology and Medicine 123: 889
• 10 Cohen P, Derksen A. 1969; Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. British Journal of Haematology 17: 359
• 11 Condrea E, De Vries A, Mayer J. 1962; Action of snake venom phospholipase A on free and lipoprotein-bound phospholipids. Biochimica et Biophysica Acta 58: 389
• 12 Davey MG, Lüscher EF. 1965; Action of some coagulant snake venoms upon blood platelets. Nature (London) 207: 1037
• 13 Davey MG, Luscher EF. 1967; Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature (London) 216: 857
• 14 Davis JW, Yue KT N, Phillips PE. 1972; The effect of neuraminidase on platelet aggregation induced by ADP, norepinephrine, collagen or serotonin. Thrombosis et Diathesis Haemorrhagica 28: 221
• 15 Day HJ, Holmsen H, Zucker MB. 1975; Methods for separating platelets from blood and plasma. Thrombosis et Diathesis Haemorrhagica 33: 648
• 16 Derksen A, Cohen P. 1975; Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. Journal of Biological Chemistry 250: 9342
• 17 Didisheim P, Kazmier FJ, Fuster V. 1974; Platelet inhibition in the management of thrombosis. Thrombosis et Diathesis Haemorrhagica 32: 21
• 18 Feinstein M, Fiekers J, Fraser C. 1976; An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion. Journal of Pharmacology and Experimental Therapeutics 197: 215
• 19 Flower RJ, Blackwell GJ. 1976; The importance of phospholipase A₂ in prostaglandin biosynthesis. Biochemical Pharmacology 25: 285
• 20 Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF. 1975; Effects on platelet function of removal of platelet sialic acid by neuraminidase. Laboratory Investigations 32: 476
• 21 Hamberg M, Svensson J, Samuelsson B. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences 72: 2994
• 22 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; a Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences 71: 345
• 23 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; b Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proceedings of the National Academy of Sciences 71: 3400
• 24 Hampton J. 1971; Trends in the development of antithrombotic agents. American Journal of Cardiology 27: 659
• 25 Harbury CB, Hershagold JE, Schrier SL. 1972; Requirements for aggregation of washed human platelets suspended in buffered salt solutions. Thrombosis et Diathesis Haemorrhagica 28: 2
• 26 Haslam RJ. 1964; Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature 202: 765
• 27 Haslam RJ. 1973; Interactions of the pharmacological receptors of blood platelets with adenyl cyclase. Seminar Haematologica 6: 333
• 28 Haslam RJ, Lynham JA. 1972; Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. Life Science 11: 1143
• 29 HIRSH J, GENT M, GENTON E. 1975; The current status of platelet suppressive drugs in the treatment of thrombosis. Thrombosis et Diathesis Haemorrhagica 33: 406
• 30 Hovig T. 1963; Aggregation of rabbit blood platelets produced in vitro by “saline extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 248
• 31 Jesse RL, Cohen P. 1976; Arachidonic acid release from diacyl phosphatidylethanolamine by human platelet membranes. Biochemical Journal 158: 283
• 32 Kazimierczak W, Peret M, Máslínski C. 1976; The action of local anesthetics on histamine release. Biochemical Pharmacology 25: 1747
• 33 Kirschmann C, Aloof S, De Vries A. 1963; Action of lysolecithin on blood platelets. Thrombosis et Diathesis Haemorrhagica 9: 512
• 34 Kirschmann C, Condrea E, Moau N. 1964; Action of snake venom on human platelet phospholipids. Archives of the International Pharmacodyn 150: 372
• 35 Kolata GB. 1975; Thromboxanes: The power behind the prostaglandins. Science 190 770: 812
• 36 Leone G, Boni P, Vinceti A. 1976; Platelet aggregation by thimerosal, role of ADP and SH groups. Thrombosis and Haemostasis 35: 249
• 37 Macfarlane DE, Mills DC B. 1975; The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 46: 309
• 38 Macmillan DC. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by ADP and adrenaline. Nature (London) 211: 140
• 39 Markus HB, Ball EG. 1969; Inhibition of lypolytic process in rat diphose tissue by antimalarial drugs. Biochimica et Biophysica Acta 187: 486
• 40 Markwardt F, Barthel W, Glusa E, Hoffmann A. 1966; N-S Archives of Experimental Pathology. Pharmacology 252: 297
• 41 Markwardt F, Hoffmann A. 1970; Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets. Biochemical Pharmacology 19: 2519
• 42 Marney SR. 1971; Platelet aggregation in heparinized plasma and citrated plasma. Relationship to ADP and inhibition by cobra factor. Journal of Immunology 106: 82
• 43 Mcnicol GP, Mitchell JR A, Reuter H, Van De Loo J. 1970; Platelet in thrombosis, their clinical significance and the evaluation of potential drugs. Thrombosis et Diathesis Haemorrhagica 31: 379
• 44 Meyer CJ, Van Breemen C, Casteels R. 1972; The action of Lanthanum and D600 on the calcium exchange in the smooth muscle cells of the guinea-pig taenia coli. Pflueeers Archives 337 333
• 45 Michel H, Caen JP, Born GV R, Miller R, Auriac GA, Meyer P. 1976; Relation between the inhibition of aggregation and the concentration of c-AMP in human and rat platelets. British Journal of Haematology 33: 27
• 46 Mustard JF, Perry DW, Ardlie NG, Packham MA. 1972; Preparation of suspensions of washed platelets from humans. British Journal of Haematology 22: 193
• 47 Nye SW, Graham JB, Brinkhous KM. 1962; The partial thromboplastin time as a screening test for the detection of latent bleeders. American Journal of Medical Science 243: 279
• 48 O’Brien JR. 1962; Platelet aggregation. II. Some results from a new method of study. Journal of Clinical Pathology 15: 452
• 49 Ouyang C, Teng CM. 1977 Purification and characterization of the platelet aggregation principle of Trimeresurus mucrosquamatus venom. Submitted for publication in Biochimica et Biophysica Acta.
• 50 Packham MA, Warrior ES, Glynn MF, Senyi AS, Mustard JF. 1967; Alternation of the response of platelet to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171
• 51 Patscheke H, Brossmer R. 1975; Concanavalin A-induced aggregation of human blood platelets. Ca⁺⁺-dependent and Ca⁺⁺-independent effects. Thrombosis et Diathesis Haemorrhagica 33: 354
• 52 Praga CA, Pogliani EM. 1973; Effect of temperature on ADP-induced platelet aggregation. Thrombosis et Diathesis Haemorrhagica 29: 183
• 53 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. 1976; In vitro and in vivo functions of thrombin-treated platelets. Thrombosis et Diathesis Haemorrhagica 35: 151
• 54 Roth GJ, Majerus PW. 1975; The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein. Journal of Clinical Investigation 56: 624
• 55 Salzman EW, Levine L. 1971; Cyclic 3’,5’-adenosine monophosphate in human blood platelets. II. Effect of N⁶-2’-0-dibutyryl cyclic 3’,5’-adenosine monophosphate on platelet function. Journal of Clinical Investigation 50: 131
• 56 Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. 1975; Annual Review of Biochemistry. 44: 669
• 57 Saxon A, Kattlove HE. 1976; Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. Blood 47. 951
• 58 Shtacher G, Crowley HJ, Dolton C. 1976; Inhibition of platelet aggregation by papaverinelike drugs: evidence for a novel mechanism of action. Biochemical Pharmacology 25: 1045
• 59 Simard-Duquesne N. 1973; Enhancement by ADP of thrombin-induced aggregation in ADP- refractory platelets. Thrombosis et Diathesis Haemorrhagica 29: 445
• 60 Sket D, Gubensek F. 1976; Pharmacological study of phospholipase A from Vipera ammodytes venom. Toxicon 14: 393
• 61 Strong PN, Goerke J, Oberg G, Kelly RB. 1976; P-Bungarotoxin, a pre-synaptic toxin with enzymatic activity. Proceedings of the National Academy of Sciences USA 73: 178
• 62 Thomson D, Forbes CD, Prentice CR M. 1973; A comparison of the effects of antihistamines on platelet function. Thrombosis et Diathesis Haemorrhagica 30: 547
• 63 Ungaro PC, Beck TM, Mccaa WM, Hershagold EJ. 1973; The in vivo and in vitro effect of antihistamines on platelet aggregation. Thrombosis et Diathesis Haemorrhagica 30: 597
• 64 Vane JR. 1971; Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology) 231: 232
• 65 Vargaftic BB, Hai ND. 1972; Selective inhibition by mepacrine of the release of »rabbit aorta contracting substance« evoked by the administration of bradykinin. Journal of Pharmacy and Pharmacology 24: 159
• 66 Verhaeghe RH, Shepherd JT. 1976; Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels. Journal of Pharmacology Experimental Therapeutics 199: 269
• 67 Warlow C, Corina A, Ogston D, Douglas AS. 1974; The relationship between platelet aggregation and time interval after venepuncture. Thrombosis and Diathesis Haemorrhagica 31: 133
• 68 WEISS HJ. 1976; Antiplatelet drugs - A new pharmacologic approach to the prevention of thrombosis. American Heart Journal 92: 86
• 69 Yue KT N, Davis JW, Aldridge EG. 1973; Effect of aspirin and benadryl on human platelet oxidative phosphorylation and aggregation. Thrombosis et Diathesis Haemorrhagica 30: 577
• 70 Zucker MB, Peterson J. 1968; Inhibition of adenosine diphosphate induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society of Experimental Biology and Medicine 127: 547